Treatment usage by treatment group over the 1-year follow-up period
| Treatment type | Usual care (n=944) | Proactive outreach (n=826) | OR* | p Value |
|---|---|---|---|---|
| Medication | ||||
| Any medication† | 278 (29.5%) | 335 (40.6%) | 1.63 (1.34–2.00) | <0.001 |
| NRT | 192 (20.5%) | 275 (33.8%) | 1.99 (1.60–2.48) | <0.001 |
| Bupropion/varenicline | 104 (11.1%) | 105 (12.9%) | 1.19 (0.89–1.59) | 0.249 |
| Counselling | ||||
| Any counselling | 45 (4.8%) | 174 (21.1%) | 5.42 (3.83–7.66) | <0.001 |
| Phone | 27 (2.9%) | 155 (19.4%) | 8.08 (5.29–12.33) | <0.001 |
| In-person | 23 (2.6%) | 72 (9.4%) | 3.87 (2.38–6.29) | <0.001 |
| Combination | ||||
| None reported | 655 (69.4%) | 461 (55.8%) | 0.55 (0.45–0.68) | <0.001 |
| Medication only | 244 (25.9%) | 191 (23.1%) | 0.85 (0.68–1.06) | 0.150 |
| Counselling only | 11 (1.2%) | 30 (3.6%) | 3.21 (1.60–6.47) | 0.001 |
| Medication and counselling | 34 (3.6%) | 144 (17.4%) | 5.69 (3.85–8.40) | <0.001 |
| Any cessation treatment used | 289 (30.6%) | 365 (44.2%) | 1.81 (1.48–2.21) | <0.001 |
Data are n (%) or OR (95% CI).
*Adjusted for stratification variables of age, sex and insurance type.
†Participants could report using more than one medication.
NRT, nicotine replacement therapy.